Vice President, Open Health Systems Laboratory, Inc.
Dr. Bhat is responsible for OHSL’s various policy-related activities and programs. He is an expert in global health policy and pharmaceutical systems and industry. With a deep background in government and industry, Dr. Bhat has amassed considerable knowledge and experience of how different governments approach the mandate of assuring the health of its citizens, while enabling local industry, particularly healthcare and life sciences, to grow and succeed. As a specialist in science policy, Dr. Bhat is adept in various types of policy analyses and studies, including surveys, assessments, and policy reviews for a variety of clients.
OHSL was conceived to focus on building global team science consortia by leveraging the best biomedical informatics, information and communication technology to address the key questions of medical science and to provide a quicker and better global public health response. We accomplish this by engaging participants to shape the agenda and goals and to encourage collaboration in building capacity for collective action to resolve problems.
In addition to his work at OHSL, Dr. Bhat is also the Managing Director of A6 Strategies, LLC, which provides consultation and advice to a number of firms and organizations interested in the Indian life sciences market, advising on government relations and the business & regulatory environment.
From 2014 to 2016, Dr. Bhat was President of TwoFour Insight Group, LLC, a firm focused on providing information and insight on market entry and regulatory environment to U.S.-based life sciences companies interested in the Indian market. Prior to TwoFour Insight, Dr. Bhat was an Assistant Vice President for International Affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA) where he advocated on behalf of member companies in front of governments across Asia on policy issues related to market access, intellectual property and pricing.
Dr. Bhat began his career with the U.S. Government, working in the Fogarty International Center of the U.S. National Institutes of Health, and later serving as the first Director of the Asia-Pacific office within the Office of the U.S. Secretary of Health and Human Services, building a team of health representatives and attachés positioned throughout Asia. During his time in the U.S. Government, Dr. Bhat negotiated dozens of bilateral agreements with foreign governments and developed an in-depth knowledge of the health systems across Asia and the Pacific. While at HHS, Dr. Bhat worked on a number of key policy and programmatic activities such as the Global Fund and PEPFAR, as well as the U.S. Government’s response to various epidemics and natural disasters. Through these various roles, Dr. Bhat also developed a keen understanding of the role of biomedical research and the development of experimental therapies into commercializable products.
Dr. Bhat has a Ph.D. from The George Washington University in Public Policy (Science & Technology Policy), a Master’s in Public Policy from Duke University, and a Bachelor’s in Chemistry, also from Duke University. His doctoral dissertation was on the Economic Impact of Biomedical Research.